Figure 9.
Survival analysis for patients with ccRCC based on two gene panels. Performance of a panel of four collagen genes with co‐expression in the matched pairs data (A and B). Performance of a panel of eleven genes with superior rank hazard ratio, and their expression level in risk groups (C and D). The genes have been selected based on their performance in the survival analysis from a set of 20 genes with highest TU/NO‐fold change listed in Table 2.